COSSU, MARIA VITTORIA

COSSU, MARIA VITTORIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 2-gen-2020 Di Cristo, ValentinaVitiello, PaolaCossu, Maria VittoriaColella, ElisaRusconi, Stefano + Article (author) -
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 2-ott-2018 Capetti ARusconi SGiacomelli ACOSSU, MARIA VITTORIA + Article (author) -
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48weeks' observational data 30-set-2017 M.V. CossuS. Rusconi + Article (author) -
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents 11-feb-2019 Giacomet, VaniaCossu, Maria V.Capetti, Amedeo F.Zuccotti, Gian Vincenzo + Article (author) -
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV 1-gen-2023 Maria Vittoria CossuAndrea GiacomelliAmedeo CapettiSpinello Antinori + Article (author) -
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 1-gen-2021 Giacomelli, AndreaBonazzetti, CeciliaConti, FedericoPezzati, LauraMicheli, ValeriaMancon, AlessandroAlbrecht, MariaPasserini, MatteoCossu, Maria VittoriaCapetti, Amedeo FerdinandoAntinori, SpinelloGalli, Massimo + Article (author) -
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 2-dic-2019 Capetti, AmedeoCossu, Maria VittoriaGiacomelli, AndreaRusconi, Stefano + Article (author) -
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 1-gen-2014 M.V. CossuD. CattaneoS. FucileP. PellegrinoS. BaldelliV. CozziA. CapettiE. Clementi Article (author) -
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 1-feb-2015 D. CattaneoM.V. CossuS. FucileA. RivaS. BaldelliC. ResnatiM. GalliE. ClementiA. Capetti + Article (author) -
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 1-gen-2020 Antinori, SpinelloCossu, Maria VittoriaBonazzetti, CeciliaPagani, GabrieleBorghi, BeatriceMileto, DavideRusconi, StefanoGismondo, Maria RitaGiacomelli, AndreaGalli, Massimo + Article (author) -
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 1-gen-2023 Rizzo, AlbertoPozza, GiacomoSalari, FedericaGiacomelli, AndreaMileto, DavideCossu, Maria VittoriaMancon, AlessandroGagliardi, GloriaMicol, BianchiMicheli, ValeriaCapetti, AmedeoAntinori, SpinelloGismondo, Maria RitaLombardi, Alessandra + Article (author) -
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects 30-nov-2022 Borgonovo, FabioStangalini, Carlo AlbertoMileto, DavideCossu, Maria VittoriaGagliardi, GloriaCutrera, MiriamCapetti, Amedeo F + Article (author) -
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data 1-ago-2018 Capetti, Amedeo FerdinandoCossu, Maria VittoriaRusconi, Stefano + Article (author) -
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 28-gen-2017 Capetti A.Rusconi S.Cossu M. V. + Article (author) -
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 1-mag-2021 Passerini, MatteoPiscaglia, MarcoMorena, ValentinaGiacomelli, AndreaFalvella, StefaniaCossu, Maria VittoriaCapetti, Amedeo F + Article (author) -
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients 12-set-2019 Rusconi, StefanoCapetti, AmedeoCossu, Maria Vittoria + Article (author) -
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients 29-giu-2016 S. PiconiV. RainoneM. CossuM. MasettiM. ClericiD. Trabattoni + Article (author) -
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 1-giu-2020 Morena V.Bestetti G.Fossali T.Bassoli C.Torre A.Cossu M. V.Minari C.Ballone E.Mileto D.Merli S.Foschi A.Vimercati S.Bradanini L.Micheli V.Galli M.Antinori S. + Article (author) -
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 1-gen-2020 Cossu M. V.Menzaghi B.Di Cristo V.Valenti D.Gori A. + Article (author) -
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort 23-set-2016 A.F. CapettiM.V. CossuS. RusconiN. Riccardi + Article (author) -